Seasonality Snapshot

Amgen (AMGN)

Biotechnology · US · US Healthcare & Biotech
✓ VERIFIED · 15YR REAL DATA
JanFebMarAprMayJunJulAugSepOctNovDec
NEUTRAL SEASONALITY — October
Strongest Month
July
+5.63% avg · 88% win rate
Weakest Month
September
-1.27% avg · 44% win rate
MonthAvg ReturnWin Rate
January +1.51% 63%
February +0.67% 56%
March +1.67% 63%
April +0.12% 38%
May +0.63% 38%
June +1.71% 63%
July +5.63% 88%
August +2.27% 69%
September -1.27% 44%
October NOW +1.47% 50%
November +3.32% 80%
December +0.25% 47%
These figures are computed from 15 years of actual monthly closing prices. Past seasonal patterns are not a guarantee of future performance. See our methodology for how this is calculated, or visit the Academy to learn how to read seasonal data responsibly.

Amgen seasonality — common questions

What is Amgen's best month historically?
Historically, July has been Amgen's strongest month, averaging +5.63% with a 88% win rate over 15 years of data. September has been the weakest at -1.27%.
Is Amgen seasonal?
Amgen shows a measurable seasonal pattern: its best and worst months differ by 6.90 percentage points on average. These figures come from 15 years of real monthly closing prices. Seasonality is a historical tendency, not a prediction.
How does Amgen historically perform in October?
Amgen is currently in October, which has historically averaged +1.47% with a 50% win rate. That is a historically neutral window.

Get the full analysis

Backtest this seasonal pattern, compare it against other assets, set alerts, and explore detrended & presidential-cycle views.

Open the Analyzer →
TimingAX is an independently operated service, not a registered investment adviser. This page is for informational purposes only and is not financial advice.